The question of whether patients with myasthenia gravis need to take bromipyridamole for life is a problem for every patient with myasthenia gravis. In clinical practice, we often encounter patients with well-controlled conditions who always ask whether or not they can stop taking bromipyridamole, and when they can stop taking it. The first thing we need to know is that bromipyridamole is an allopathic drug, not for the cause of severe muscle disease itself. The use of bromipyridamole can effectively improve the symptoms of myasthenia gravis in patients. Myasthenia gravis is an autoimmune disease caused by damage to acetylcholine receptors on the postsynaptic membrane of the nerve-muscle junction, and the action of bromipyridamole is simply to inhibit the activity of cholinesterase, causing a decrease in the destruction of acetylcholine released from nerve endings, thereby increasing the amount of acetylcholine in the synaptic gap. This mechanism of action of bromipyridamole does not involve the pathogenesis of heavy muscle, i.e., immune disorders. Therefore, bromipyridamole is only a symptomatic drug. Patients with immune disorders should still be targeted with hormones or other immunosuppressive drugs, but of course, these clinical drugs should be used under the guidance of experienced physicians, and patients should not add or subtract from them at will. In some patients, with effective treatment, the condition of heavy muscle can be controlled well, the clinical muscle weakness symptoms have been effectively improved, and the condition is relatively stable. The need to continue to take bromipyridamole has no great impact on the disease itself, at this time can be considered to stop bromipyridamole. At this stage, some patients may still need to continue taking hormones or other immunosuppressive drugs. The other thing is that all of this must happen under the guidance of an experienced clinician, and you must not add or subtract at will! In summary, patients with stable, well-controlled severe muscle can have their dose of bromipyridamole reduced or even discontinued under the guidance of an experienced physician.